Evidence map›Paper›PMID 30574124›Full record

ArticleFrontiers in microbiology2018

Hospitalized Pets as a Source of Carbapenem-Resistance.

Fabio Gentilini, Maria Elena Turba, Frederique Pasquali, Domenico Mion, Noemi Romagnoli, Elisa Zambon, Daniele Terni, Gisele Peirano, Johann Dawid Daniel Pitout, Antonio Parisi and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 1 synthesis or guideline pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Genomic Characterization of Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2025
    Article
  5. Carbapenem-resistant bacteria in the environment.Arhiv za higijenu rada i toksikologiju · 2025
    Review
  6. Outbreak of Carbapenem-Resistant High-Risk Clone ST244 ofAntibiotics (Basel, Switzerland) · 2025
    Article
  7. Article
  8. Review
  9. Review
  10. Microorganisms · 2024
    Review
  11. Emergence of pandrug-resistant carbapenemase-producingFrontiers in cellular and infection microbiology · 2024
    Article
  12. Article
  13. Predominance ofVeterinarni medicina · 2023
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Fabio GentiliniDepartment of Veterinary Medical Sciences, University of Bologna, Bologna, Italy.
Maria Elena TurbaGenefast Srl, Forlì, Italy.
Frederique PasqualiDepartment of Agricultural and Food Sciences, University of Bologna, Bologna, Italy.
Domenico MionDepartment of Veterinary Medical Sciences, University of Bologna, Bologna, Italy.
Noemi RomagnoliDepartment of Veterinary Medical Sciences, University of Bologna, Bologna, Italy.
Elisa ZambonOspedale: Veterinario I Portoni Rossi s.r.l., Bologna, Italy.
Daniele TerniOspedale: Veterinario I Portoni Rossi s.r.l., Bologna, Italy.
Gisele PeiranoUnit of Microbiology, University of Calgary and Calgary Laboratory Services, Calgary, AB, Canada.
Johann Dawid Daniel PitoutUnit of Microbiology, University of Calgary and Calgary Laboratory Services, Calgary, AB, Canada.
Antonio ParisiIstituto Zooprofilattico Sperimentale della Puglia e della Basilicata, Foggia, Italy.
Vittorio SambriThe Great Romagna Hub Laboratory, Pievesestina, Italy.
Renato Giulio ZanoniDepartment of Veterinary Medical Sciences, University of Bologna, Bologna, Italy.
University of Bologna · ITCalgary Laboratory Services · CAIstituto Zooprofilattico Sperimentale della Puglia e della Basilicata · ITUniversity of Calgary · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The massive and irrational use of antibiotics in livestock productions has fostered the occurrence and spread of resistance to "old class antimicrobials." To cope with that phenomenon, some regulations have been already enforced in the member states of the European Union. However, a role of livestock animals in the relatively recent alerts on the rapid worldwide increase of resistance to last-choice antimicrobials as carbapenems is very unlikely. Conversely, these antimicrobials are increasingly administered in veterinary hospitals whose role in spreading bacteria or mobile genetic elements has not adequately been addressed so far. A cross-sectional study was carried out on 105 hospitalized and 100 non-hospitalized pets with the aim of measuring the prevalence of carbapenem-resistant Gram-negative bacteria (GNB) colonizing dogs and cats, either hospitalized or not hospitalized and estimating the relative odds. Stool samples were inoculated on MacConkey agar plates containing 1 mg/L imipenem which were then incubated aerobically at 37°C ± 1 for 48 h. Isolated bacteria were identified first by Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and were confirmed by 16S rRNA sequencing. The genetic basis of resistance was investigated using PCR methods, gene or whole genome sequencing (WGS). The prevalence of pets harboring carbapenem-resistant bacteria was 11.4 and 1.0% in hospitalized and not-hospitalized animals, respectively, with an odds ratio of 12.8 (

Indexed as

Acinetobacter radioresistensblaNDM-1blaOXA-23carbapenem resistancedogs and catshospitalizationone healthveterinary tertiary care facilities

Identifiers

PMID30574124
PMCPMC6291488
OpenAlexW2904646038

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.